Insights into the role of substrates on the interaction between cytochrome b5 and cytochrome P450 2B4 by NMR

Scientific Reports

Volumn 5, Issue , 2014, Pages

  Zhang, Meng ^a   Le Clair, Stéphanie V ^a   Huang, Rui ^a   Ahuja, Shivani ^a   Im, Sang Choul ^b   Waskell, Lucy ^b   Ramamoorthy, Ayyalusamy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME B5; CYTOCHROME P-450 CYP2B4 (RABBIT); PROTEIN BINDING; SODIUM CHLORIDE; UNSPECIFIC MONOOXYGENASE;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; ENZYME SPECIFICITY; METABOLISM; NUCLEAR MAGNETIC RESONANCE; OSMOLARITY; PROTEIN CONFORMATION;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROMES B5; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OSMOLAR CONCENTRATION; PROTEIN BINDING; PROTEIN CONFORMATION; SODIUM CHLORIDE; SUBSTRATE SPECIFICITY;

EID: 84923346691     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08392     Document Type: Article

References (53)

1. Dürr, U. H. N.,Waskell, L.&Ramamoorthy,A. The cytochromes P450 and b5 and their reductases-promising targets for structural studies by advanced solid-state NMR spectroscopy. Biochim. Biophys. Acta 1768, 3235-59 (2007).
2. Guengerich, F. P., Wu, Z.-L. & Bartleson, C. J. Function of human cytochrome P450s: characterization of the orphans. Biochem. Biophys. Res. Commun. 338, 465-9 (2005).
3. Nebert, D. W. & Russell, D. W. Clinical importance of the cytochromes P450. Lancet 360, 1155-62 (2002).
4. Danielson, P. B. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr. Drug Metab. 3, 561-597 (2002).
5. Ortiz de Montellano, P. R. Hydrocarbon hydroxylation by cytochrome P450 enzymes. Chem. Rev. 110, 932-48 (2010).
6. Guengerich, F. P. Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J. 8, E101-11 (2006).
7. Konopka, K. The Stoichiometry of the Cytochrome P-450-catalyzed Metabolism of Methoxyflurane and Benzphetamine in the Presence and Absence of Cytochrome b5. J. Biol. Chem. 270, 24707-24718 (1995).
8. Zhang, H., Hamdane, D., Im, S.-C. & Waskell, L. Cytochrome b5 inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P450 2B4. J. Biol. Chem. 283, 5217-25 (2008).
9. Im, S.-C. & Waskell, L. The interaction ofmicrosomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b5. Arch. Biochem. Biophys. 507, 144-53 (2011).
10. Hulsker, R., Baranova, M. V., Bullerjahn, G. S. & Ubbink, M. Dynamics in the transient complex of plastocyanin-cytochrome f from Prochlorothrix hollandica. J. Am. Chem. Soc. 130, 1985-91 (2008).
11. Bashir, Q., Scanu, S. & Ubbink, M. Dynamics in electron transfer protein complexes. FEBS J. 278, 1391-400 (2011).
12. Worrall, J. A. R. et al. Myoglobin and cytochrome b5: a nuclear magnetic resonance study of a highly dynamic protein complex. Biochemistry 41, 11721-30 (2002).
13. Schreiber, G. & Fersht, A. R. Rapid, electrostatically assisted association of proteins. Nat. Struct. Biol. 3, 427-431 (1996).
14. Crowley, P. B. & Ubbink, M. Close encounters of the transient kind: protein interactions in the photosynthetic redox chain investigated by NMR spectroscopy. Acc. Chem. Res. 36, 723-30 (2003).
15. Ubbink, M. The courtship of proteins: understanding the encounter complex. FEBS Lett. 583, 1060-6 (2009).
16. Suh, J.-Y., Tang, C. & Clore, G. M. Role of electrostatic interactions in transient encounter complexes in protein-protein association investigated by paramagnetic relaxation enhancement. J. Am. Chem. Soc. 129, 12954-5 (2007).
17. Zhang, H., Myshkin, E. & Waskell, L. Role of cytochrome b5 in catalysis by cytochrome P450 2B4. Biochem. Biophys. Res. Commun. 338, 499-506 (2005).
18. Finn, R. D. et al. Defining the in vivo role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5. J. Biol. Chem. 283, 31385-93 (2008).
19. McLaughlin, L. A., Ronseaux, S., Finn, R. D., Henderson, C. J. & Roland Wolf, C. Deletion of microsomal cytochrome b5 profoundly affects hepatic and extrahepatic drug metabolism. Mol. Pharmacol. 78, 269-78 (2010).
20. Zhang, H., Im, S.-C. & Waskell, L. Cytochrome b5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4. J. Biol. Chem. 282, 29766-76 (2007).
21. Gruenke, L. D., Konopka, K., Cadieu, M. & Waskell, L. The stoichiometry of the cytochrome P-450-catalyzed metabolism of methoxyflurane and benzphetamine in the presence and absence of cytochrome b5. J. Biol. Chem. 270, 24707-18 (1995).
22. Tamburini, P., White, R. & Schenkman, J. Chemical characterization of proteinprotein interactions between cytochrome P-450 and cytochrome b5. J. Biol. Chem. 260, 4007-4015 (1985).
23. Estrada, D. F., Laurence, J. S. & Scott, E. E. Substrate-modulated cytochrome P450 17A1 and cytochrome b5 interactions revealed by NMR. J. Biol. Chem. 288, 17008-18 (2013).
24. Ahuja, S. et al. A model of the membrane-bound cytochrome b5-cytochrome P450 complex from NMR and mutagenesis data. J. Biol. Chem. 288, 22080-95 (2013).
25. Shah, M. B. et al. A structural snapshot of CYP2B4 in complex with paroxetine provides insights into ligand binding and clusters of conformational states. J. Pharmacol. Exp. Ther. 346, 113-20 (2013).
26. Zhang, H. et al. Potent mechanism-based inactivation of cytochrome P450 2B4 by 9-ethynylphenanthrene: implications for allosteric modulation of cytochrome P450 catalysis. Biochemistry 52, 355-64 (2013).
27. Shah,M. B. et al. Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules. Biochemistry 51, 7225-7238 (2012).
28. Gay, S. C. et al. Structural Analysis of Mammalian Cytochrome P450 2B4 Covalently Bound to the Mechanism-Based Inactivator tert- Butylphenylacetylene: Insight into Partial Enzymatic Activity. Biochemistry 50, 4903-4911 (2011).
29. Wilderman, P. R. et al. Plasticity of cytochrome P450 2B4 as investigated by hydrogen-deuterium exchange mass spectrometry and X-ray crystallography. J. Biol. Chem. 285, 38602-11 (2010).
30. Gay, S. C. et al. Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel. Biochemistry 49, 8709-20 (2010).
31. Gay, S. C., Sun, L.,Maekawa, K., Halpert, J. R. & Stout, C. D. Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1Himidazole: ligand-induced structural response through alpha-helical repositioning. Biochemistry 48, 4762-71 (2009).
32. Zhao, Y. et al. Structural and thermodynamic consequences of 1-(4- chlorophenyl)imidazole binding to cytochrome P450 2B4. Biochemistry 46, 11559-11567 (2007).
33. Zhao, Y. et al. Structure ofmicrosomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction. J. Biol. Chem. 281, 5973-81 (2006).
34. Scott, E. E. et al. Structure of mammalian cytochrome P450 2B4 complexed with 4- (4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding. J. Biol. Chem. 279, 27294-301 (2004).
35. Scott, E. E. et al. An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution. Proc. Natl. Acad. Sci. U. S. A. 100, 13196-201 (2003).
36. Mulrooney, S. B. & Waskell, L. High-level expression in Escherichia coli and purification of the membrane-bound form of cytochrome b5. Protein Expr. Purif. 19, 173-178 (2000).
37. Bridges, A. et al. Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase. J Biol Chem 273, 17036-17049 (1998).
38. Dürr, U. H. N., Yamamoto, K., Im, S.-C., Waskell, L. & Ramamoorthy, A. Solidstate NMR reveals structural and dynamical properties of a membrane-anchored electron-carrier protein, cytochrome b5. J. Am. Chem. Soc. 129, 6670-1 (2007).
39. Goddard, T. D. & Kneller, D. G. SPARKY 3, University of California, San Francisco.
40. Voznesensky, A. I. & Schenkman, J. B. The cytochrome P450 2B4-NADPH cytochrome P450 reductase electron transfer complex is not formed by chargepairing. J. Biol. Chem. 267, 14669-14676 (1992).
41. Adam, G. & Delbruck, M. Reduction of dimensionality in biological diffusion processes in: Structural Chemistry and Molecular Biology (Rich, A. and Davidson, N., Ed.). 198-215 (1968).
42. Crowley, P. B. et al. The interactions of cyanobacterial cytochrome c6 and cytochrome f, characterized by NMR. J. Biol. Chem. 277, 48685-9 (2002).
43. Hervás, M., Navarro, J. A., Díaz, A. & De la Rosa, M. A. A comparative thermodynamic analysis by laser-flash absorption spectroscopy of photosystem I reduction by plastocyanin and cytochrome c6 in Anabaena PCC 7119, Synechocystis PCC 6803 and Spinach. Biochemistry 35, 2693-8 (1996).
44. Schreiber, G. & Fersht, A. R. Interaction of barnase with its polypeptide inhibitor barstar studied by protein engineering. Biochemistry 32, 5145-50 (1993).
45. Garrett, D. S., Seok, Y. J., Peterkofsky, A., Gronenborn, A. M. & Clore, G. M. Solution structure of the 40,000 Mr phosphoryl transfer complex between the Nterminal domain of enzyme I and HPr. Nat. Struct. Biol. 6, 166-73 (1999).
46. Halpert, J. R. Structure and function of cytochromes P450 2B: from mechanismbased inactivators to X-ray crystal structures and back. Drug Metab. Dispos. 39, 1113-21 (2011).
47. Sheinerman, F. B., Norel, R. & Honig, B. Electrostatic aspects of protein-protein interactions. Curr. Opin. Struct. Biol. 10, 153-159 (2000).
48. Janin, J. The kinetics of protein-protein recognition. Proteins 28, 153-61 (1997).
49. Clackson, T. & Wells, J. A. A hot spot of binding energy in a hormone-receptor interface. Science 267, 383-6 (1995).
50. Dolinsky, T. J. et al. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 35, W522-5 (2007).
51. Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665-7 (2004).
52. DeLano, W. L. The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC. (2010). at ,http://www.pymol.org/citing.
53. Baker, N. A., Sept, D., Joseph, S., Holst, M. J. &McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. U. S. A. 98, 10037-41 (2001).